Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The French Registry on the First-line Treatment of Non High-risk Acute Promyelocytic Leukemia (APL) in Patients Aged ≤ 70 Years

NCT02938858 is registered in ClinicalTrials.gov with Groupe Francophone des Myelodysplasies as lead sponsor.

NCT NCT02938858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02938858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The French Registry on the First-line Treatment of Non High-risk Acute Promyelocytic Leukemia (APL) in Patients Aged ≤ 70 Years
Lead sponsor
Groupe Francophone des Myelodysplasies
Phase
Observational
Overall status
Completed
Start date
October 31, 2015
Completion date
July 31, 2026
Enrollment
400 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

acute promyelocytic leukemia